Medicare Enrolled
Dr. Jack Mann, M.D.
Pulmonary Disease · Bayside, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mann from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mann?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mann
Dr. Jack Mann is a pulmonary disease specialist in Bayside, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Mann performed 2,651 Medicare services across 1,563 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mann received a total of $729,745 from 37 pharmaceutical and/or device companies across 1236 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mann is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 15% volume in NY
$729,745 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,651
Medicare services
Top 15% in NY for pulmonary disease
1,563
Unique beneficiaries
$79
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~133 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
494 | $113 | $325 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
267 | $63 | $154 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
189 | $17 | $35 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
185 | $31 | $474 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
152 | $37 | $398 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
148 | $157 | $314 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
144 | $42 | $181 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
144 | $55 | $208 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
107 | $110 | $250 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
98 | $8 | $15 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
98 | $200 | $602 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
96 | $70 | $153 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
82 | $84 | $274 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
54 | $158 | $350 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
54 | $160 | $311 |
| Change of breathing tube in windpipe | 49 | $28 | $101 |
| COVID-19 amplified DNA/RNA probe detection A laboratory test that uses amplified DNA or RNA probes to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) antigen. |
48 | $50 | $187 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 30 | $20 | $30 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
30 | $34 | $35 |
| Artery puncture collection of blood sample | 28 | $26 | $100 |
| New patient office visit, complex (60-74 min) | 27 | $187 | $767 |
| Initial nursing facility care, moderate complexity Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes. |
27 | $132 | $283 |
| Blood gas test with oxygen saturation A test that measures the levels of gases in the blood, including oxygen saturation. |
26 | $77 | $113 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
21 | $76 | $122 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
15 | $152 | $175 |
| Smoking cessation counseling, more than 10 minutes Intensive counseling session focused on helping patients quit smoking and tobacco use, lasting more than 10 minutes. |
14 | $32 | $45 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
13 | $12 | $160 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing patterns, and sleep duration. This test records physiological data while you sleep to assess your sleep quality and breathing function. |
11 | $131 | $750 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$729,745
Total received (2018-2024)
Avg $104,249/year across 7 years
Top 0% in NY for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
1,236
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$710,097 (97.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$13,783 (1.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,865 (0.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$50,638
2023
$44,351
2022
$120,644
2021
$120,680
2020
$151,134
2019
$181,045
2018
$61,253
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Mallinckrodt Hospital Products Inc.
$44,509
Boehringer Ingelheim Pharmaceuticals, Inc.
$5,037
GlaxoSmithKline, LLC.
$237
Insmed, Inc.
$169
Takeda Pharmaceuticals U.S.A., Inc.
$118
AstraZeneca Pharmaceuticals LP
$111
GENZYME CORPORATION
$99
Bayer Healthcare Pharmaceuticals Inc.
$79
Philips North America LLC
$70
Actelion Pharmaceuticals US, Inc.
$60
Grifols USA, LLC
$28
ANI Pharmaceuticals, Inc.
$27
Baxter Healthcare
$27
Amgen Inc.
$20
Regeneron Healthcare Solutions, Inc.
$20
PFIZER INC.
$14
Mylan Specialty L.P.
$13
Top 3 companies account for 98.3% of 2024 payments
All-time payments by company (2018-2024) ›
Mallinckrodt Hospital Products Inc.
$311,973
GlaxoSmithKline, LLC.
$145,512
Boehringer Ingelheim Pharmaceuticals, Inc.
$98,636
Mallinckrodt Enterprises LLC
$74,812
Insmed, Inc.
$37,955
Mallinckrodt LLC
$19,046
Sunovion Pharmaceuticals Inc.
$18,911
Mylan Specialty L.P.
$17,901
Actelion Pharmaceuticals US, Inc.
$1,016
Grifols USA, LLC
$567
Philips Electronics North America Corporation
$479
Advanced Respiratory, Inc
$301
Baxter Healthcare
$275
Bayer HealthCare Pharmaceuticals Inc.
$272
Genentech USA, Inc.
$234
Regeneron Healthcare Solutions, Inc.
$210
Takeda Pharmaceuticals U.S.A., Inc.
$202
GENZYME CORPORATION
$198
AstraZeneca Pharmaceuticals LP
$178
Bayer Healthcare Pharmaceuticals Inc.
$129
Medtronic MiniMed, Inc.
$123
ANI Pharmaceuticals, Inc.
$110
United Therapeutics Corporation
$99
Janssen Pharmaceuticals, Inc
$87
Amgen Inc.
$71
Philips North America LLC
$70
Merck Sharp & Dohme Corporation
$66
Merck Sharp & Dohme LLC
$61
Gilead Sciences, Inc.
$52
Shire North American Group Inc
$50
Exeltis, USA Inc.
$36
Teva Pharmaceuticals USA, Inc.
$29
Phadia US Inc.
$20
JAZZ PHARMACEUTICALS INC.
$19
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$16
PFIZER INC.
$14
Circassia Pharmaceuticals Inc
$12
Top 3 companies account for 76.2% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (8944) Trilogy Evo Universal · (AK6) Vest Therapy · ACTHAR · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · ARALAST · Adempas · Arikayce · BROVANA · CYCLOSET · DUAKLIR PRESSAIR · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · DreamStat Cpap Auto · DreamWear Pillows · ELIQUIS · Esbriet · FASENRA · GLASSIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · ImmunoCAP · JARDIANCE · LONHALA MAGNAIR · Letairis · Life 2000 Ventilation System · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · PURIFIED CORTROPHIN GEL · Perforomist · Prolastin-C · Prolastin-C Liquid · Respiratoriy Care Undiv · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO · STIOLTO RESPIMAT · SUNOSI · Sleep Other · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · The Monarch Airway Clearance System · The Vest System Model 105 Home Care · The VisiVest Airway Clearance System · Trilogy 100 · UPTRAVI · UTIBRON NEOHALER · Utibron · Wellcentive Undiv · XARELTO · Xolair · YUPELRI · Yupelri · iPro2 · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (97%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for pulmonary disease in NY.
Geographic Context
Pulmonary diseases within 10 mi
646
Per 100K population
27.7
County median income
$84,961
Nearest hospital
NEW YORK-PRESBYTERIAN/QUEENS
2.7 mi
2.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mann is a clinical cardiology specialist, with above-average Medicare volume (top 15% in NY), with speaking/promotional industry engagement in the top 0% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mann experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Mann performed 494 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mann receive payments from pharmaceutical companies?
Yes. Dr. Mann received a total of $729,745 from 37 companies across 1,236 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mann's costs compare to other pulmonary diseases in Bayside?
Dr. Mann's average Medicare payment per service is $79. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mann) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Bayside
Browse pulmonary diseases in Bayside ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NY
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NY
Which NY pulmonary diseases receive the most from drug and device companies.
By company
Mallinckrodt Hospital Products Inc. Payments to Doctors
See all physicians who received payments from Mallinckrodt Hospital Products Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology